NOF (TSE:4403) Stock Can Revenue Strength Offset Its Profit Squeeze

NOF went into this earnings print with the stock drifting, down about 15% over three months and trading below an analyst discounted cash flow estimate. However, the latest quarter did not deliver the kind of clean beat that might quickly reset sentiment. The headline is compression in profit rather than sales weakness. Revenue in Q1 2027 came in at ¥69,007m, while net income was ¥7,571m, which pulled basic earnings per share back to ¥33.52. For a company often treated as a steady compounder in chemicals, this margin squeeze is what the market is now testing.

Is NOF now a genuine bargain after this profit squeeze, or is the lower share price simply fair for slower growth? Compare the current market price with our valuation analysis for NOF

Q1 2027 Earnings Summary

• Revenue (Q1 2027 vs. Q1 2026): ¥69,007m vs. ¥56,063m (higher year on year)
• Net Income (Excl. Extra Items, Q1 2027 vs. Q1 2026): ¥7,571m vs. ¥8,610m (decline year on year)
• Basic EPS (Q1 2027 vs. Q1 2026): ¥33.52 vs. ¥37.00 (decline year on year)
• Trailing Net Profit Margin (Last 12 Months vs. Prior Year): 14.6% vs. 14.2% (modest improvement)

Prefer clean, visual charts to another block of earnings text and margin figures? See NOF's full financial picture, including how its latest profit squeeze fits into the broader valuation context, in the company report for NOF.

Revenue Resilience Supports NOF Bullish Arguments

For investors leaning positive on NOF as a diversified chemicals and healthcare materials company, the latest figures offer some support. Revenue in Q1 2027 was ¥69,007m compared with ¥56,063m a year earlier, which fits the idea of a broad, multi segment business that can find pockets of demand even when some areas are under pressure. The trailing net profit margin of 14.6% also sits slightly above the prior 14.2%. That supports the view that this is not a purely low margin commodity chemicals story.

Margin Pressure Keeps NOF Bear Concerns Alive

The bearish angle focuses on earnings quality, and Q1 2027 gives that view some traction. Net income fell from ¥8,610m to ¥7,571m and basic EPS slipped from ¥37.00 to ¥33.52 even with higher sales. That points to cost pressure or mix issues that matter for a company often described as a steady compounder. With the share price down over 14% across 90 days, the market reaction aligns with concern that profitability is under strain despite the revenue headline.

With profit squeezed and the share price at ¥2,750.5, the key question is whether NOF’s balance sheet and cash generation can comfortably support dividends and reinvestment. Check the full liquidity and debt breakdown in the financial health analysis of NOF stock.

Stay Ahead With Simply Wall St

With NOF balancing firm revenue against recent profit pressure, this is a moment when timing and context really matter. Register for free with Simply Wall St and add NOF to your Watchlist to track its share price against fair value and watch for an entry point that fits your plan. Once you hold the stock, keep on top of only the most important developments and cut through noise with the Portfolio Command Center. Then round out your research with crowd insights by tapping into the Community so you can spot potential catalysts or risks early and stay a step ahead of the market.

Seeking Alternatives Beyond NOF Right Now

Fresh ideas move fast and the best setups rarely wait. Scan these focused stock shortlists while they are still under the radar for now and get in early.

• Spot companies with solid earnings power and robust balance sheets using the curated list of solid balance sheet and fundamentals stocks (40 results) before momentum traders get caught chasing late moves.
• Target businesses with staying power and meaningful income streams by reviewing the hand picked 43 dividend fortresses while yields and prices still line up for disciplined buyers.
• Zero in on resilient opportunities with measured risk by scanning the filtered 56 resilient stocks with low risk scores before the crowd starts pushing valuations higher and choices begin dropping away.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com